What is the IDDI?
The Innovative Drug Development Initiative (IDDI) is a transformational activity within the PVRI that facilitates the development of novel treatments for patients with pulmonary hypertension (PH) and right ventricular failure, establishing them into clinical practice.
All active PVRI members who are interested in contributing to this activity are encouraged to join the Task Force.